share_log

Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $2 Price Target

Benzinga ·  Aug 27, 2024 13:53  · Ratings

Benchmark analyst Bruce Jackson reiterates Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and maintains $2 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment